Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments

被引：17

作者：

He, Zan ^{[1
]}

Xin, Zijuan ^{[2
,3
,4
,5
]}

Yang, Qiong ^{[2
,3
,4
,5
]}

Wang, Chen ^{[2
,3
,4
,5
]}

Li, Meng ^{[2
,3
,4
,5
]}

Rao, Wei ^{[1
]}

Du, Zhimin ^{[1
]}

Bai, Jia ^{[1
]}

Guo, Zixuan ^{[6
]}

Ruan, Xiuyan ^{[2
,3
,4
,5
]}

Zhang, Zhaojun ^{[2
,3
,4
,5
]}

Fang, Xiangdong ^{[2
,3
,4
,5
]}

Zhao, Hua ^{[1
]}

机构：

[1] Peoples Liberat Army, Dept Dermatol, Med Gen Hosp 1, Beijing, Peoples R China

[2] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China

[3] Chinese Acad Sci, China Natl Ctr Bioinformat, Beijing, Peoples R China

[4] Univ Chinese Acad Sci, Beijing, Peoples R China

[5] Beijing Key Lab Genome & Precis Med Technol, Beijing, Peoples R China

[6] Peoples Liberat Army, Sr Dept Orthoped, Gen Hosp, Med Ctr 4, Beijing, Peoples R China

来源：

ELIFE | 2022年 / 11卷

基金：

中国国家自然科学基金;

关键词：

acral melanoma; single-cell RNA sequencing; tumor microenvironment; Human; Skin; IMMUNE CELLS; CANCER; FIBROBLASTS; METASTASIS; HALLMARKS; CARCINOMA; EXCLUSION; BLOCKADE; SURVIVAL; BIOLOGY;

D O I：

10.7554/eLife.78616

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Acral melanoma (AM) exhibits a high incidence in Asian patients with melanoma, and it is not well treated with immunotherapy. However, little attention has been paid to the characteristics of the immune microenvironment in AM. Therefore, in this study, we collected clinical samples from Chinese patients with AM and conducted single-cell RNA sequencing to analyze the heterogeneity of its tumor microenvironments (TMEs) and the molecular regulatory network. Our analysis revealed that genes, such as TWIST1, EREG, TNFRSF9, and CTGF could drive the deregulation of various TME components. The molecular interaction relationships between TME cells, such as MIF-CD44 and TNFSF9-TNFRSF9, might be an attractive target for developing novel immunotherapeutic agents.

引用

页数：24

共 56 条

[31] Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy [J].

Li, Jiannong ;

Smalley, Inna ;

Chen, Zhihua ;

Wu, Jheng-Yu ;

Phadke, Manali S. ;

Teer, Jamie K. ;

Nguyen, Thanh ;

Karreth, Florian A. ;

Koomen, John M. ;

Sarnaik, Amod A. ;

Zager, Jonathan S. ;

Khushalani, Nikhil I. ;

Tarhini, Ahmad A. ;

Sondak, Vernon K. ;

Rodriguez, Paulo C. ;

Messina, Jane L. ;

Chen, Y. Ann ;

Smalley, Keiran S. M. .

CLINICAL CANCER RESEARCH, 2022, 28 (10) :2131-2146

[32] Extracellular Matrix Degradation and Remodeling in Development and Disease [J].

Lu, Pengfei ;

Takai, Ken ;

Weaver, Valerie M. ;

Werb, Zena .

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2011, 3 (12)

[33] Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy [J].

McKean, Meredith A. ;

Amaria, Rodabe N. .

CANCER TREATMENT REVIEWS, 2018, 70 :144-153

[34] Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients [J].

Nakamura, Y. ;

Namikawa, K. ;

Yoshino, K. ;

Yoshikawa, S. ;

Uchi, H. ;

Goto, K. ;

Fukushima, S. ;

Kiniwa, Y. ;

Takenouchi, T. ;

Uhara, H. ;

Kawai, T. ;

Hatta, N. ;

Funakoshi, T. ;

Teramoto, Y. ;

Otsuka, A. ;

Doi, H. ;

Ogata, D. ;

Matsushita, S. ;

Isei, T. ;

Hayashi, T. ;

Shibayama, Y. ;

Yamazaki, N. .

ANNALS OF ONCOLOGY, 2020, 31 (09) :1198-1206

[35] The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis [J].

Noma, Kazuhiro ;

Smalley, Keiran S. M. ;

Lioni, Mercedes ;

Naomoto, Yoshio ;

Tanaka, Noriaki ;

El-Deiry, Waflk ;

King, Alastair J. ;

Nakagawa, Hiroshi ;

Herlyn, Meenhard .

GASTROENTEROLOGY, 2008, 134 (07) :1981-1993

[36] Current biology of VEGF-B and VEGF-C [J].

Olofsson, B ;

Jeltsch, M ;

Eriksson, U ;

Alitalo, K .

CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (06) :528-535

[37]

Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]

[38] limma powers differential expression analyses for RNA-sequencing and microarray studies [J].

Ritchie, Matthew E. ;

Phipson, Belinda ;

Wu, Di ;

Hu, Yifang ;

Law, Charity W. ;

Shi, Wei ;

Smyth, Gordon K. .

NUCLEIC ACIDS RESEARCH, 2015, 43 (07) :e47

[39] Nivolumab in Previously Untreated Melanoma without BRAF Mutation [J].

Robert, Caroline ;

Long, Georgina V. ;

Brady, Benjamin ;

Dutriaux, Caroline ;

Maio, Michele ;

Mortier, Laurent ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

McNeil, Catriona ;

Kalinka-Warzocha, Ewa ;

Savage, Kerry J. ;

Hernberg, Micaela M. ;

Lebbe, Celeste ;

Charles, Julie ;

Mihalcioiu, Catalin ;

Chiarion-Sileni, Vanna ;

Mauch, Cornelia ;

Cognetti, Francesco ;

Arance, Ana ;

Schmidt, Henrik ;

Schadendorf, Dirk ;

Gogas, Helen ;

Lundgren-Eriksson, Lotta ;

Horak, Christine ;

Sharkey, Brian ;

Waxman, Ian M. ;

Atkinson, Victoria ;

Ascierto, Paolo A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :320-330

[40] Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy [J].

Rose, April A. N. ;

Armstrong, Susan M. ;

Hogg, David ;

Butler, Marcus O. ;

Saibil, Samuel D. ;

Arteaga, Diana P. ;

Muniz, Thiago Pimentel ;

Kelly, Deirdre ;

Ghazarian, Danny ;

King, Ian ;

Kamil, Zaid Saeed ;

Ross, Kendra ;

Spreafico, Anna .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)

← 1 2 3 4 5 6 →